International Journal of Epidemiology 2000;29:891-898
© International Epidemiological Association 2000
Use of comorbidity scores for control of confounding in studies using administrative databases
a Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA.
b Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
c Pharmacare, Ministry of Health, British Columbia, Canada.
Reprint requests to: Sebastian Schneeweiss, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Ave, Boston, MA 02115, USA. E-mail: sschneew{at}hsph.harvard.edu
Background Comorbidity scores are increasingly used to reduce potential confounding in epidemiological research. Our objective was to compare metrical and practical properties of published comorbidity scores for use in epidemiological research with administrative databases.
Methods The literature was searched for studies of the validity of comorbidity scores as predictors of mortality and health service use, as measured by change in the area under the receiver operating characteristic (ROC) curve for dichotomous outcomes, and change in R 2 for continuous outcomes.
Results Six scores were identified, including four versions of the Charlson Index (CI) which use either the three-digit International Classification of Diseases, Ninth Revision (ICD-9) or the full ICD-9-CM (clinical modification) code, and two versions of the Chronic Disease Score (CDS) which used outpatient pharmacy records. Depending on the population and exposure under study, predictive validities varied between c = 0.64 and c = 0.77 for in-hospital or 30-day mortality. This is only a slight improvement over age adjustment. In one study the simple measure ‘number of diagnoses’ outperformed the CI (c = 0.73 versus c = 0.65). Proprietary scores like Ambulatory Diagnosis Groups and Patient Management Categories do not necessarily perform better in predicting mortality. Comorbidity indices are susceptible to a variety of coding errors.
Conclusions Comorbidity scores, particularly the CDS or D'Hoore's CI based on three-digit ICD-9 codes, may be useful in exploratory data analysis. However, residual confounding by comorbidity is inevitable, given how these scores are derived. How much residual confounding usually remains is something that future studies of comorbidity scores should examine. In any given study, better control for confounding can be achieved by deriving study-specific weights, to aggregate comorbidities into groups with similar relative risks of the outcomes of interest.
Keywords Comorbidity, confounding, risk adjustment, health services epidemiology, clinical epidemiology
Accepted 13 March 2000
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. Browne, C. Cook, S. A. Olson, and M. P. Bolognesi Resident Duty-Hour Reform Associated with Increased Morbidity Following Hip Fracture J. Bone Joint Surg. Am., September 1, 2009; 91(9): 2079 - 2085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Baron, O. Schieir, M. Hudson, R. Steele, A. Janelle-Montcalm, J. Bernstein, M. Starr, M. Gagne, M. Stein, H. Kang, et al. Evaluation of the clinimetric properties of the Early Inflammatory Arthritis--self-administered comorbidity questionnaire Rheumatology, April 1, 2009; 48(4): 390 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Min, N. Kang, L. J. Shaw, R. B. Devereux, M. Robinson, F. Lin, A. P. Legorreta, and A. Gilmore Costs and Clinical Outcomes after Coronary Multidetector CT Angiography in Patients without Known Coronary Artery Disease: Comparison to Myocardial Perfusion SPECT1 Radiology, October 1, 2008; 249(1): 62 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. McAlister, D. T. Eurich, S. R. Majumdar, and J. A. Johnson The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy Eur J Heart Fail, July 1, 2008; 10(7): 703 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tang, J. Y. Wan, and J. E. Bailey Performance of Comorbidity Measures to Predict Stroke and Death in a Community-Dwelling, Hypertensive Medicaid Population Stroke, July 1, 2008; 39(7): 1938 - 1944. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N Armitage, N. Sibanda, P. J Cathcart, M. Emberton, and J. H P v. d. Meulen Mortality in men admitted to hospital with acute urinary retention: database analysis BMJ, December 8, 2007; 335(7631): 1199 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F A McAlister, S R Majumdar, D T Eurich, and J A Johnson The effect of specialist care within the first year on subsequent outcomes in 24 232 adults with new-onset diabetes mellitus: population-based cohort study Qual. Saf. Health Care, February 1, 2007; 16(1): 6 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Holmes, L. J. Kozak, and M. F. Owings Use And In-Hospital Mortality Associated With Two Cardiac Procedures, By Sex And Age: National Trends, 1990-2004 Health Aff., January 1, 2007; 26(1): 169 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Halpern, Z. M. Khan, J. K. Schmier, M. Burnier, J. J. Caro, J. Cramer, W. L. Daley, J. Gurwitz, and N. K. Hollenberg Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data Hypertension, June 1, 2006; 47(6): 1039 - 1048. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Y. Park-Wyllie, D. N. Juurlink, A. Kopp, B. R. Shah, T. A. Stukel, C. Stumpo, L. Dresser, D. E. Low, and M. M. Mamdani Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults N. Engl. J. Med., March 30, 2006; 354(13): 1352 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Tai, P. Dick, T. To, and J. G. Wright Development of Pediatric Comorbidity Prediction Model Arch Pediatr Adolesc Med, March 1, 2006; 160(3): 293 - 299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Eurich, S. R. Majumdar, F. A. McAlister, R. T. Tsuyuki, and J. A. Johnson Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure Diabetes Care, October 1, 2005; 28(10): 2345 - 2351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D C Saltman, G P Sayer, and S D Whicker Co-morbidity in general practice Postgrad. Med. J., July 1, 2005; 81(957): 474 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. McGregor, P. W. Kim, E. N. Perencevich, D. D. Bradham, J. P. Furuno, K. S. Kaye, J. C. Fink, P. Langenberg, M.-C. Roghmann, and A. D. Harris Utility of the Chronic Disease Score and Charlson Comorbidity Index as Comorbidity Measures for Use in Epidemiologic Studies of Antibiotic-resistant Organisms Am. J. Epidemiol., March 1, 2005; 161(5): 483 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Curry, C. W. Hanson III, M. W. Russell, C. Hanna, G. Devine, and E. A. Ochroch The Use and Effectiveness of Electrocardiographic Telemetry Monitoring in a Community Hospital General Care Setting Anesth. Analg., November 1, 2003; 97(5): 1483 - 1487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. van Manen, J. C. Korevaar, F. W. Dekker, E. W. Boeschoten, P. M. M. Bossuyt, and R. T. Krediet Adjustment for Comorbidity in Studies on Health Status in ESRD Patients: Which Comorbidity Index to Use? J. Am. Soc. Nephrol., February 1, 2003; 14(2): 478 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schneeweiss, J. D. Seeger, M. Maclure, P. S. Wang, J. Avorn, and R. J. Glynn Performance of Comorbidity Scores to Control for Confounding in Epidemiologic Studies using Claims Data Am. J. Epidemiol., November 1, 2001; 154(9): 854 - 864. [Abstract] [Full Text] [PDF]
|
|